Abstract:With high prevalence of type 2 diabetes worldwide, diabetic complications have been a major health problem, which reduce life quality and induce premature death in adults. The prevalence of type 2 diabetes is closely related to obesity and aging, two major risk factors for metabolic disorders. The diabetic complications, including retinopathy, nephropathy, neuropathy, skin ulcer, and atherosclerosis, are risk factors for mortality of patients. Retinopathy, nephropathy, and skin ulcer are representatives of microvascular complications, which often happen in insulin-deficient diabetic conditions, such as type 1 diabetic patients and some late-stage type 2 diabetic patients when β-cells completely lose function. Atherosclerosis that is often found in type 2 diabetes is a complication of macrovascular disease that increases the risk for myocardial infarction and strokes. However, atherosclerosis is receiving more and more appreciation in type 1 diabetes. Endothelial cells that line the inner vessel have been extensively studied in the mechanism of the diabetic complications. Impaired endothelial cell function is a common cellular mechanism for most of the diabetic complications (retinopathy, nephropathy, skin ulcer, and atherosclerosis). The cells are exposed to the high level of glucose in diabetic condition and subjected to glucose-induced stresses. The stress may cause overproliferation and deficiency in proliferation of endothelial cells, which contribute to dysfunction of microcirculation. Prevention and treatment of the complications are dependent on protection of the endothelial cell functions in most cases. In this issue, the mechanism of endothelial cell dysfunction was investigated in several studies to understand the molecular events by which the endothelial cells are impaired by hyperglycemia. This topic is enhanced with another group of studies about intervention of the endothelial complications with antioxidant compounds and new drug candidates. These studies will help readers to understand the current status and gain new insights into the diabetic complications. Weiping Jia Aimin Xu Alex Chen Jiarui Wu Jianping Ye

The mechanisms of glycolipid metabolism disorder on vascular injury in type 2 diabetes

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Mechanistic insights into glucose induced vascular epigenetic reprogramming in type 2 diabetes

Chronic Vascular Complications in Diabetes

Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction

Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications

Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications

To Explore the Pathogenesis of Vascular Lesion of Type 2 Diabetes Mellitus Based on the PI3K/Akt Signaling Pathway

Extracellular vesicles in type 2 diabetes mellitus: key roles in pathogenesis, complications, and therapy

Endothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability

Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy

Diabetic vascular diseases: molecular mechanisms and therapeutic strategies

Molecular Mechanisms and Clinical Insights

Diabetic Endothelium Dysfunction, Cardiovascular Complications, and Therapeutics

Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus

Type 2 Diabetes Mellitus-associated Structural Alteration of Glycans in Glycoconjugates

The role of glucagon-like peptide-1/GLP-1R and autophagy in diabetic cardiovascular disease

Molecular Pathology and Therapeutic Strategies of Type 2 Diabetes

Epigenetic Regulation in Diabetic Vascular Complications

Pathophysiology of Type 2 Diabetes Mellitus